July 2016 in “Cancer Research” This study found that male pattern baldness was associated with an increased risk of skin cancer at the head and neck, particularly affecting the scalp.
November 2015 in “Hair transplant forum international” PRP may help with hair regrowth in male pattern baldness, but more research is needed.
Plan hair-restoration surgery early for better results in male pattern baldness.
August 2013 in “Hospital Pharmacy” This article discusses the importance of recognizing adverse drug reactions, methods of prevention, and encourages reporting them to the FDA's MedWatch program; it reports no new results.
Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.
April 2012 in “The Journal of Urology” In this prospective cohort study, male pattern baldness was identified as an independent predictor of prostate cancer, while the 2D:4D finger ratio was not associated with the cancer risk.
Targeting a specific lipid could help treat male pattern baldness.
March 2012 in “Dermatology Times E-News” Men with pattern baldness may have a higher risk of prostate issues.
January 2012 in “Chinese Journal of Aesthetic Medicine” This study found that in hair follicles, androgen receptor expression is stronger in the hair loss and transitional areas compared to the occipital region, suggesting a role in male pattern baldness.
September 2011 in “Hair transplant forum international” This commentary discusses the ongoing debate about the advisability of initiating hair transplants in people with early-stage male or female pattern baldness and does not present new research findings.
Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.
January 2009 in “Revista de Ciências Médicas” This review summarizes various treatment options for male androgenetic alopecia, noting that few demonstrate effective results, and reports no new clinical findings.
January 2007 in “Inpharma Weekly” Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.
January 2007 in “Annals of The Royal College of Surgeons of England” This case report describes a 64-year-old woman with male pattern hair loss and elevated testosterone levels, who was diagnosed with an androgen-secreting adrenal tumor and successfully treated with laparoscopic adrenalectomy.
May 2004 in “Dermatologic Surgery” In this study, 32% of men continued taking finasteride for androgenetic alopecia after 1 to 3 years, but only a small percentage reported hair growth.
December 2002 in “International Journal of Cosmetic Surgery and Aesthetic Dermatology” This study investigated a potential link between male pattern baldness and Pityrosporum group fungal contamination but found no significant statistical association.
January 2001 in “Chinese Journal of Medical Aesthetics and Cosmetology” In this study, the use of micrografts for male pattern hair loss led to natural hair growth and patient satisfaction, despite low hair density and the potential need for multiple procedures.
January 2000 in “Journal watch” This study from Finland suggests that insulin resistance might be the connecting factor between early-onset androgenetic alopecia and coronary artery disease in men under 35.
This review discusses the causes, current therapies, and potential developments for male pattern baldness and reports no new clinical findings.
Surgical treatments like hair transplants can help with male pattern baldness.
February 2023 in “Cureus” This study found a significant association between the severity of male pattern baldness and increased levels of depression, loneliness, and internet addiction among male medical students with androgenetic alopecia.
August 2021 in “Journal of The American Academy of Dermatology” This article discusses metabolomics in the context of finasteride treatment for male pattern baldness and reports no new clinical results.
April 2021 in “Texila international journal of academic research” In this randomized clinical trial, researchers reported that both topical and systemic finasteride treatments were similarly effective in increasing hair counts and terminal hair in men with androgenic alopecia after more than 3 months of follow-up.
March 2020 in “Zenodo (CERN European Organization for Nuclear Research)” Finasteride treatment changes certain urine metabolites in male pattern baldness patients.
February 2020 in “Zenodo (CERN European Organization for Nuclear Research)” Finasteride treatment changes urine metabolites in male pattern baldness patients.
June 2017 in “IP Indian journal of clinical and experimental dermatology” This study found that using a combination of 10% topical minoxidil, oral finasteride, and microneedling for six months effectively improved male pattern baldness with moderate to excellent responses and high patient satisfaction, without major side effects among the 25 participants.
November 2017 in “Journal of cosmetology & trichology” The combined treatment of a specific hair cocktail and microneedling device effectively restores hair in different baldness patterns.
Results are not reported for this study, which used a directed acyclic graph to analyze the association between chest hair amount and prostate cancer, adjusting for age and ancestry.
140 citations
,
October 2008 in “Nature Genetics” 34 citations
,
April 1982 in “BMJ”